Exact Mass: 285.1859308
Exact Mass Matches: 285.1859308
Found 471 metabolites which its exact mass value is equals to given mass value 285.1859308,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Piperine
Piperine, also known as fema 2909, belongs to the class of organic compounds known as alkaloids and derivatives. These are naturally occurring chemical compounds that contain mostly basic nitrogen atoms. This group also includes some related compounds with neutral and even weakly acidic properties. Also some synthetic compounds of similar structure are attributed to alkaloids. In addition to carbon, hydrogen and nitrogen, alkaloids may also contain oxygen, sulfur and more rarely other elements such as chlorine, bromine, and phosphorus. Piperine is a pepper tasting compound. Piperine is found in the highest concentration within pepper (Piper nigrum) and many other Piper species. Piperine has also been detected, but not quantified, in dills and herbs and spices. Piperine is responsible for the hot taste of pepper. Piperine has been used in trials studying the treatment of Multiple Myeloma and Deglutition Disorders. It is used to impart pungent taste to brandy. Piperine is a N-acylpiperidine that is piperidine substituted by a (1E,3E)-1-(1,3-benzodioxol-5-yl)-5-oxopenta-1,3-dien-5-yl group at the nitrogen atom. It is an alkaloid isolated from the plant Piper nigrum. It has a role as a NF-kappaB inhibitor, a plant metabolite, a food component and a human blood serum metabolite. It is a member of benzodioxoles, a N-acylpiperidine, a piperidine alkaloid and a tertiary carboxamide. It is functionally related to an (E,E)-piperic acid. Bioperine has been used in trials studying the treatment of Multiple Myeloma and Deglutition Disorders. Piperine is a natural product found in Macropiper, Piper boehmeriifolium, and other organisms with data available. See also: Black Pepper (part of) ... View More ... Constituent of pepper (Piper nigrum) and many other Piper subspecies (Piperaceae). It is used to impart pungent taste to brandy. Responsible for the hot taste of pepper. Flavour ingredient. Piperine is found in dill, herbs and spices, and pepper (spice). A N-acylpiperidine that is piperidine substituted by a (1E,3E)-1-(1,3-benzodioxol-5-yl)-5-oxopenta-1,3-dien-5-yl group at the nitrogen atom. It is an alkaloid isolated from the plant Piper nigrum. Piperine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=94-62-2 (retrieved 2024-07-01) (CAS RN: 94-62-2). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Piperine, a natural alkaloid isolated from Piper nigrum L, inhibits P-glycoprotein and CYP3A4 activities with an IC50 value of 61.94±0.054 μg/mL in HeLa cell. Piperine, a natural alkaloid isolated from Piper nigrum L, inhibits P-glycoprotein and CYP3A4 activities with an IC50 value of 61.94±0.054 μg/mL in HeLa cell.
Machiline
C17H19NO3 (285.13648639999997)
(R)-coclaurine is a coclaurine. It is an enantiomer of a (S)-coclaurine. (R)-Coclaurine is a natural product found in Mezilaurus synandra, Stephania excentrica, and other organisms with data available.
Coclaurine
C17H19NO3 (285.13648639999997)
(S)-coclaurine is the (S)-enantiomer of coclaurine. It is a conjugate base of a (S)-coclaurinium. It is an enantiomer of a (R)-coclaurine. Coclaurine is a natural product found in Delphinium pentagynum, Damburneya salicifolia, and other organisms with data available. Coclaurine, also known as (r,s)-coclaurine or machiline, is a member of the class of compounds known as benzylisoquinolines. Benzylisoquinolines are organic compounds containing an isoquinoline to which a benzyl group is attached. Coclaurine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Coclaurine can be found in custard apple and soursop, which makes coclaurine a potential biomarker for the consumption of these food products. Coclaurine is a nicotinic acetylcholine receptor antagonist which has been isolated from a variety of plant sources including Nelumbo nucifera, Sarcopetalum harveyanum, Ocotea duckei, and others. It belongs to the class of tetrahydroisoquinoline alkaloids. Dimerization of coclaurine leads to the biscoclaurine alkaloids such as cepharanthine .
Aposcopolamine
C17H19NO3 (285.13648639999997)
Aposcopolamine is an alkaloid that can be isolated from Datura ferox. Aposcopolamin can closely binds with ACHE, ADRA2A and CHRM2. Aposcopolamine can be used for the research of Alzheimer's disease[1]. Aposcopolamine is an alkaloid that can be isolated from Datura ferox. Aposcopolamin can closely binds with ACHE, ADRA2A and CHRM2. Aposcopolamine can be used for the research of Alzheimer's disease[1]. Aposcopolamine is an alkaloid that can be isolated from Datura ferox. Aposcopolamin can closely binds with ACHE, ADRA2A and CHRM2. Aposcopolamine can be used for the research of Alzheimer's disease[1].
Norcodeine
C17H19NO3 (285.13648639999997)
Norcodeine is a metabolite of codeine. Norcodeine is an opiate analogue that is the N-demethylated derivative of codeine. Norcodeine has relatively little opioid activity in its own right, but is formed as a metabolite of codeine following ingestion. (Wikipedia) D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist > C1657 - Opiate
Morphine
C17H19NO3 (285.13648639999997)
Morphine, also known as (-)-morphine or morphine sulfate, is a member of the class of compounds known as morphinans. Morphinans are polycyclic compounds with a four-ring skeleton with three condensed six-member rings forming a partially hydrogenated phenanthrene moiety, one of which is aromatic while the two others are alicyclic. Morphine is soluble (in water) and a very weakly acidic compound (based on its pKa). Morphine can be synthesized from morphinan. Morphine is also a parent compound for other transformation products, including but not limited to, myrophine, heroin, and codeine. Morphine can be found in a number of food items such as nanking cherry, eggplant, millet, and common hazelnut, which makes morphine a potential biomarker for the consumption of these food products. Morphine can be found primarily in blood and urine, as well as in human kidney and liver tissues. In humans, morphine is involved in several metabolic pathways, some of which include heroin action pathway, morphine metabolism pathway, heroin metabolism pathway, and codeine metabolism pathway. Morphine is a non-carcinogenic (not listed by IARC) potentially toxic compound. Morphine is a drug which is used for the relief and treatment of severe pain. The primary source of morphine is isolation from poppy straw of the opium poppy. In 2013, an estimated 523 000 kg of morphine were produced. About 45 000 kg were used directly for pain, a four-time increase over the last twenty years. Most use for this purpose was in the developed world. About 70\\% of morphine is used to make other opioids such as hydromorphone, oxymorphone, and heroin. It is a Schedule II drug in the United States, Class A in the United Kingdom, and Schedule I in Canada. It is on the World Health Organizations List of Essential Medicines, the most effective and safe medicines needed in a health system. Morphine is sold under many trade names . Primarily hepatic (90\\%), converted to dihydromorphinone and normorphineand is) also converted to morphine-3-glucuronide (M3G) and morphine-6-glucuronide. Virtually all morphine is converted to glucuronide metabolites; only a small fraction (less than 5\\%) of absorbed morphine is demethylated (DrugBank). In the treatment of morphine overdosage, primary attention should be given to the re- establishment of a patent airway and institution of assisted or controlled ventilation. Supportive measures (including oxygen, vasopressors) should be employed in the management of circulatory shock and pulmonary edema accompanying overdose as indicated. Cardiac arrest or arrhythmias may require cardiac massage or defibrillation. The pure opioid antagonists, such as naloxone, are specific antidotes against respiratory depression which results from opioid overdose. Naloxone should be administered intravenously; however, because its duration of action is relatively short, the patient must be carefully monitored until spontaneous respiration is reliably re-established. If the response to naloxone is suboptimal or not sustained, additional naloxone may be administered, as needed, or given by continuous infusion to maintain alertness and respiratory function; however, there is no information available about the cumulative dose of naloxone that may be safely administered (L1712) (T3DB). Morphine is the principal alkaloid in opium and the prototype opiate analgesic and narcotic. In 2017, morphine was the 155th most commonly prescribed medication in the United States, with more than four million prescriptions. Morphine is used primarily to treat both acute and chronic severe pain. Its duration of analgesia is about three to seven hours. A large overdose of morphine can cause asphyxia and death by respiratory depression if the person does not receive medical attention immediately. Morphine is naturally produced by several plants (such as the opium poppy) and animals (PMID: 22578954). Morphine was first isolated between 1803 and 1805 by Friedrich Sertürner. Sertürner originally named the substance morphium after the Greek god of dreams, Morpheus, as it has a tendency to cause sleep. The primary source of morphine is isolation from poppy straw of the opium poppy. Morphine is also endogenously produced by humans. In the mid 2000s it was found morphine can be synthesized by white blood cells (PMID 22578954). CYP2D6, a cytochrome P450 isoenzyme, catalyzes the biosynthesis of morphine from codeine and dopamine from tyramine. The morphine biosynthetic pathway in humans occurs as follows: L-tyrosine -> para-tyramine or L-DOPA -> dopamine -> (S)-norlaudanosoline -> (S)-reticuline -> 1,2-dehydroretinulinium -> (R)-reticuline -> salutaridine -> salutaridinol -> thebaine -> neopinone -> codeinone -> codeine -> morphine. (S)-Norlaudanosoline (also known as tetrahydropapaveroline) which is an important intermediate in the WBC biosynthesis of morphine can also be synthesized from 3,4-dihydroxyphenylacetaldehyde (DOPAL), a metabolite of L-DOPA and dopamine. Morphine has widespread effects in the central nervous system and on smooth muscle (PMID: 4582903). The precise mechanism of the analgesic action of morphine is not fully known. However, specific CNS opiate receptors have been identified and likely play a role in the induction of analgesic effects. Morphine first acts on the mu-opioid receptors. The mechanism of respiratory depression involves a reduction in the responsiveness of the brain stem respiratory centers to increases in carbon dioxide tension and electrical stimulation. It has been shown that morphine binds to and inhibits GABA inhibitory interneurons. These interneurons normally inhibit the descending pain inhibition pathway. So, without the inhibitory signals, pain modulation can proceed downstream. When the dose of morphine is reduced after long-term use, opioid withdrawal symptoms such as drowsiness, vomiting, and constipation may also occur (PMID: 23244430). Morphine is only found in easily detectable quantities in individuals that have used or taken this drug. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist > C1657 - Opiate N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AA - Natural opium alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.056 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054 D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 2744 CONFIDENCE standard compound; INTERNAL_ID 1580
Mepyramine
Mepyramine (also known as pyrilamine) is a first generation antihistamine, targeting the H1 receptor. However, it rapidly permeates the brain and so often causes drowsiness as a side effect. It is used in over-the-counter combination products for colds and menstrual symptoms. D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist CONFIDENCE standard compound; EAWAG_UCHEM_ID 3006 D018926 - Anti-Allergic Agents
Hydromorphone
C17H19NO3 (285.13648639999997)
Hydromorphone is only found in individuals that have used or taken this drug. It is an opioid analgesic derived from morphine and used mainly as an analgesic. It has a shorter duration of action and is more potent than morphine. [PubChem]Hydromorphone is a narcotic analgesic; its principal therapeutic effect is relief of pain. Hydromorphone interacts predominantly with the opioid mu-receptors. These mu-binding sites are discretely distributed in the human brain, with high densities in the posterior amygdala, hypothalamus, thalamus, nucleus caudatus, putamen, and certain cortical areas. They are also found on the terminal axons of primary afferents within laminae I and II (substantia gelatinosa) of the spinal cord and in the spinal nucleus of the trigeminal nerve. In clinical settings, Hydromorphone exerts its principal pharmacological effect on the central nervous system and gastrointestinal tract. Hydromorphone also binds with kappa-receptors which are thought to mediate spinal analgesia, miosis and sedation. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AA - Natural opium alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
Pentazocine
Pentazocine is only found in individuals that have used or taken this drug. It is the first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)The preponderance of evidence suggests that pentazocine antagonizes the opioid effects by competing for the same receptor sites, especially the opioid mu receptor. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AD - Benzomorphan derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics
Apohyoscine
C17H19NO3 (285.13648639999997)
Aposcopolamine is an alkaloid that can be isolated from Datura ferox. Aposcopolamin can closely binds with ACHE, ADRA2A and CHRM2. Aposcopolamine can be used for the research of Alzheimer's disease[1]. Aposcopolamine is an alkaloid that can be isolated from Datura ferox. Aposcopolamin can closely binds with ACHE, ADRA2A and CHRM2. Aposcopolamine can be used for the research of Alzheimer's disease[1]. Aposcopolamine is an alkaloid that can be isolated from Datura ferox. Aposcopolamin can closely binds with ACHE, ADRA2A and CHRM2. Aposcopolamine can be used for the research of Alzheimer's disease[1].
Coclaurine
C17H19NO3 (285.13648639999997)
Coclaurine, also known as (r,s)-coclaurine or machiline, is a member of the class of compounds known as benzylisoquinolines. Benzylisoquinolines are organic compounds containing an isoquinoline to which a benzyl group is attached. Coclaurine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Coclaurine can be found in custard apple and soursop, which makes coclaurine a potential biomarker for the consumption of these food products. Coclaurine is a nicotinic acetylcholine receptor antagonist which has been isolated from a variety of plant sources including Nelumbo nucifera, Sarcopetalum harveyanum, Ocotea duckei, and others. It belongs to the class of tetrahydroisoquinoline alkaloids. Dimerization of coclaurine leads to the biscoclaurine alkaloids such as cepharanthine .
Alprenolol hydrochloride
C15H24ClNO2 (285.14954739999996)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Alprenolol ((RS)-Alprenolol; dl-Alprenolol) hydrochloride is an orally active non-selective β-adrenoceptor antagonist and an antagonist of 5-HT1A and 5-HT1B receptors. Alprenolol hydrochloride is used as an anti-hypertensive, anti-anginal and anti-arrhythmic agent[1][2][3].
2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C308 - Immunotherapeutic Agent
1-Methyl-2-nonyl-4(1H)-quinolinone
1-Methyl-2-nonyl-4(1H)-quinolinone is a member of quinolines. 1-Methyl-2-nonylquinolin-4(1H)-one is a natural product found in Raulinoa echinata, Tetradium ruticarpum, and other organisms with data available. 1-Methyl-2-nonyl-4(1H)-quinolinone is found in herbs and spices. 1-Methyl-2-nonyl-4(1H)-quinolinone is an alkaloid from Ruta graveolens (rue
Secodemethylclausenamide
C17H19NO3 (285.13648639999997)
Secodemethylclausenamide is found in fruits. Secodemethylclausenamide is an alkaloid from Clausena lansium (wampee). Alkaloid from Clausena lansium (wampee). Secodemethylclausenamide is found in fruits.
norhydrocodone
C17H19NO3 (285.13648639999997)
norhydrocodone is a metabolite of hydrocodone. Hydrocodone or dihydrocodeinone is a semi-synthetic opioid derived from either of two naturally occurring opiates: codeine and thebaine. It is an orally active narcotic analgesic and antitussive. It is available in tablet, capsule, and syrup form. (Wikipedia) D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids
Erysopine
C17H19NO3 (285.13648639999997)
Erysopine is found in green vegetables. Erysopine is an alkaloid from Erythrina fusca (gallito
Myristoylglycine
Myristoylglycine is an acylglycine with C-14 fatty acid group as the acyl moiety. Acylglycines 1 possess a common amidoacetic acid moiety and are normally minor metabolites of fatty acids. Elevated levels of certain acylglycines appear in the urine and blood of patients with various fatty acid oxidation disorders. They are normally produced through the action of glycine N-acyltransferase which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine ↔ CoA + N-acylglycine. Myristoylglycine is an acylglycine with C-14 fatty acid group as the acyl moiety.
2-Octenoylcarnitine
2-Octenoylcarnitine is an acylcarnitine. More specifically, it is an 2-octenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Octenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-octenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(-)-Morphine
C17H19NO3 (285.13648639999997)
(-)-Morphine is found in green vegetables. (-)-Morphine is a principal alkaloid of opium (Papaver somniferum). Minor constituent of lettuce. Principal alkaloid of opium (Papaver somniferum). Minor constituent of lettuce. (-)-Morphine is found in green vegetables.
N-Monodesmethyl-rizatriptan
N-Monodesmethyl-rizatriptan is a metabolite of rizatriptan. Rizatriptan (Maxalt) is a 5-HT1 agonist triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT). Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29, 1998. It is a second-generation triptan. Rizatriptan is available only by prescription in Australia, the United States, Canada and New Zealand. (Wikipedia)
Octenoyl-L-carnitine
Octenoyl-L-carnitine is an acylcarnitine. More specifically, it is an octenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Octenoyl-L-carnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Octenoyl-L-carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2E)-Octenoylcarnitine
(2E)-Octenoylcarnitine is an acylcarnitine. More specifically, it is an (2E)-Octenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-Octenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-Octenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
3-Octenoylcarnitine
3-Octenoylcarnitine is an acylcarnitine. More specifically, it is an oct-3-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Octenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Octenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
6-Octenoylcarnitine
6-Octenoylcarnitine is an acylcarnitine. More specifically, it is an oct-6-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-Octenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-Octenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
4-Octenoylcarnitine
4-Octenoylcarnitine is an acylcarnitine. More specifically, it is an oct-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Octenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Octenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
5-Octenoylcarnitine
5-Octenoylcarnitine is an acylcarnitine. More specifically, it is an oct-5-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Octenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Octenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
2-Propylpent-4-enoylcarnitine
2-Propylpent-4-enoylcarnitine is an acylcarnitine. More specifically, it is an 2-propylpent-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Propylpent-4-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Propylpent-4-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2E)-2-Propylpent-2-enoylcarnitine
(2E)-2-Propylpent-2-enoylcarnitine is an acylcarnitine. More specifically, it is an (2E)-2-propylpent-2-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-2-Propylpent-2-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-2-Propylpent-2-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(3Z)-2-Propylpent-3-enoylcarnitine
(3Z)-2-Propylpent-3-enoylcarnitine is an acylcarnitine. More specifically, it is an (3Z)-2-propylpent-3-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3Z)-2-Propylpent-3-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (3Z)-2-Propylpent-3-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(1R,9S)-10-(Cyclopropylmethyl)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-8-one
(+)-Pentazocine
1-Tert-butyl 4-ethyl 5-oxoazepane-1,4-dicarboxylate
Acetamide, N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-
C17H19NO3 (285.13648639999997)
D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors
cis-3,4',5-Trimethoxy-3'-aminostilbene
C17H19NO3 (285.13648639999997)
Galanthaminone
C17H19NO3 (285.13648639999997)
N-Norcodeine
C17H19NO3 (285.13648639999997)
5-(1,3-Benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one
C17H19NO3 (285.13648639999997)
5-(4-Methylphenyl)-7-tert-butyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-d]pyrimidine-4-amine
Trachelanthamine
Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Pyrrolizidine alkaloids (2S,3R)-((1R,7aS)-hexahydro-1H-pyrrolizin-1-yl)methyl 2,3-dihydroxy-2-isopropylbutanoate is a natural product found in Eupatorium cannabinum, Trachelanthus korolkowii, and other organisms with data available.
1-(benzylamino)-3-(3,4-dimethylphenoxy)propan-2-ol
(-)-histrionicotoxin 285C|(?)-histrionicotoxin 285C|allodihydrohistrionicotoxin
Piperine
C17H19NO3 (285.13648639999997)
Constituent of pepper (Piper nigrum) (Piperaceae). Isopiperine is found in herbs and spices and pepper (spice). C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic Origin: Plant; SubCategory_DNP: Alkaloids derived from lysine, Piperidine alkaloids D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors Annotation level-1 MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; MXXWOMGUGJBKIW-YPCIICBESA-N_STSL_0203_Piperine_0031fmol_180831_S2_L02M02_45; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. relative retention time with respect to 9-anthracene Carboxylic Acid is 1.245 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.243 Piperine, a natural alkaloid isolated from Piper nigrum L, inhibits P-glycoprotein and CYP3A4 activities with an IC50 value of 61.94±0.054 μg/mL in HeLa cell. Piperine, a natural alkaloid isolated from Piper nigrum L, inhibits P-glycoprotein and CYP3A4 activities with an IC50 value of 61.94±0.054 μg/mL in HeLa cell.
Moiramide A|octatrienyl-D-beta-phenylalanine
C17H19NO3 (285.13648639999997)
3,6-Di-(2,3-epoxy-3-methylbutyl)-indol|ent-3,6-hexalobine C
(2R,3S)-2-acetamido-3-acetoxydodecane|clavaminol I
(2E,9Z)-N-isobutylpentadeca-2,9-diene-12,14-diynamide|2,9-Pentadecadiene-12,14-diynoic acid isobutylamide|pentadeca-2E,9Z-dien-12,14-diynoic acid isobutylamide|pentadeca-2E,9Z-diene-12,14-diynoic acid isobutylamide|pentadeca-2t,9c-dien-12,14-diynoic acid isobutylamide
2-[(Benzyloxy)amino]-3-phenylpropanoic acid methyl ester
C17H19NO3 (285.13648639999997)
N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-3-methyl-2-butenamide
pyrilamine
D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents CONFIDENCE Parent Substance with Reference Standard (Level 1); INTERNAL_ID 1700
norcodeine
C17H19NO3 (285.13648639999997)
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist > C1657 - Opiate A morphinane-like compound that is the N-demethylated derivative of codeine.
chavicine
C17H19NO3 (285.13648639999997)
hydromorphone
C17H19NO3 (285.13648639999997)
A morphinane alkaloid that is a hydrogenated ketone derivative of morphine. A semi-synthetic drug, it is a centrally acting pain medication of the opioid class. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AA - Natural opium alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
Pentazocine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AD - Benzomorphan derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics
1-methyl-2-nonylquinolin-4-one [IIN-based on: CCMSLIB00000845108]
1-methyl-2-nonylquinolin-4-one [IIN-based: Match]
Piperin
C17H19NO3 (285.13648639999997)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors Piperine, a natural alkaloid isolated from Piper nigrum L, inhibits P-glycoprotein and CYP3A4 activities with an IC50 value of 61.94±0.054 μg/mL in HeLa cell. Piperine, a natural alkaloid isolated from Piper nigrum L, inhibits P-glycoprotein and CYP3A4 activities with an IC50 value of 61.94±0.054 μg/mL in HeLa cell.
3-[[2-(dimethylamino)ethoxy](2-methylphenyl)methyl]-Phenol
3-[[2-(dimethylamino)ethoxy]phenylmethyl]-4-methyl-Phenol
(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol
(2S,6R,7S,8S)-7-((E)-buta-1,3-dien-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol
(2R,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-(pent-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol
(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-penta-2,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol
Erysopine
C17H19NO3 (285.13648639999997)
Secodemethylclausenamide
C17H19NO3 (285.13648639999997)
(-)-Morphine
C17H19NO3 (285.13648639999997)
CAR 8:1
2-(3-(tert-butoxycarbonyl)phenyl)-3-Methylpyridin-1-ium hydroxide
C17H19NO3 (285.13648639999997)
(S)-N-Boc-2-pyrrolidone-5-carboxylic acid tert-butyl ester
1-[2-Amino-1-(4-methoxyphenyl)-ethyl]-cyclohexanol hydrochloride
C15H24ClNO2 (285.14954739999996)
TERT-BUTYL 2-((TERT-BUTOXYCARBONYL)AMINO)HEX-5-ENOATE
3-BENZO[1,3]DIOXOL-5-YL-3-(2-METHOXY-PHENYL)-PROPYLAMINE
C17H19NO3 (285.13648639999997)
3-(2-ETHOXYCARBONYL-ACETYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
(R)-2-Pyrrolidineboronic acid pinanediol ester hydrochloride
3-[(1S,2S)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol,hydrochloride
C15H24ClNO2 (285.14954739999996)
1-tert-Butyl 4-ethyl 5-oxoazepane-1,4-dicarboxylate
ISOPROPYL 3-CYCLOPENTYL-1-METHYL-1H-INDOLE-6-CARBOXYLATE
N-[2-(3,4-dimethoxyphenyl)ethyl]benzamide
C17H19NO3 (285.13648639999997)
1-BOC-3-(2-MORPHOLIN-4-YL-ETHYLAMINO)-AZETIDINE
C14H27N3O3 (285.20523119999996)
2-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]acetamide
tert-butyl 4-(3-ethoxy-3-oxopropyl)piperidine-1-carboxylate
[2-(5-Cyano-1H-indol-3-yl)-ethyl]-carbamic acid tert-butyl ester
C16H19N3O2 (285.14771939999997)
N-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-2-amine
2-(3-METHYL-1H-PYRAZOL-1-YL)-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE
ditert-butyl (2S)-4-oxopyrrolidine-1,2-dicarboxylate
Benzyl [(1S)-3-hydroxy-1-phenylpropyl]carbamate
C17H19NO3 (285.13648639999997)
Ethyl [trans-4-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)cyclohe xyl]acetate
3-Methyl 1-(2-methyl-2-propanyl) 3-isopropyl-1,3-piperidinedicarb oxylate
2-Oxa-7-azaspiro[4.5]decane-3,7-dicarboxylic acid7-tert-butyl ester
N-Acetyl-N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide
C17H19NO3 (285.13648639999997)
1-O-tert-butyl 3-O-ethyl 4-oxoazepane-1,3-dicarboxylate
PHENOL, 2-(1,1-DIMETHYLETHYL)-6-(1-METHYLETHYL)-4-(3-PYRIDAZINYLAMINO)-
2-((4-HYDROXYPHENETHYL)AMINO)-1-(4-HYDROXYPHENYL)PROPAN-1-ONE
C17H19NO3 (285.13648639999997)
1-Decyl-3-methylimidazolium nitrate
C14H27N3O3 (285.20523119999996)
Piperazine, 1-[(3-formyl-1H-indol-1-yl)acetyl]-4-methyl- (9CI)
C16H19N3O2 (285.14771939999997)
ETHYL 5-(TERT-BUTYL)-2-METHYL-1-PHENYL-1H-PYRROLE-3-CARBOXYLATE
(R)-2-(2-ETHOXYCARBONYL-ACETYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
2H-1-Benzopyran-8-ol,3-(dipropylamino)-3,4-dihydro-,hydrochloride
C15H24ClNO2 (285.14954739999996)
4-METHYL-2-PHENYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)OXAZOLE
C16H20BNO3 (285.15361600000006)
9-[(2-methylpropan-2-yl)oxycarbonyl]-1-oxa-9-azaspiro[4.5]decane-3-carboxylic acid
8-(Tert-Butoxycarbonyl)-1-Oxa-8-Azaspiro[4.5]Decane-2-Carboxylic Acid
8-[(2-methylpropan-2-yl)oxycarbonyl]-1-oxa-8-azaspiro[4.5]decane-3-carboxylic acid
1-[1-(1-Benzothiophen-2-yl)cyclohexyl]pyrrolidine
N-benzyl-2-(3,4-dimethoxyphenyl)-N-methylethanamine
(5,6-DIHYDRO-4H-[1,3]THIAZIN-2-YL)-(4-ETHOXY-PHENYL)-AMINE
C17H19NO3 (285.13648639999997)
tert-Butyl spiro[indene-1,4-piperidine]-1-carboxylate
1-TERT-BUTYL 3-METHYL 3-ETHYL-4-OXOPIPERIDINE-1,3-DICARBOXYLATE
(2R)-5-Oxo-1,2-pyrrolidinedicarboxylic acid 1,2-bis(tert-butyl) ester
4-((4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)METHYL)PYRIDINE
3-[4-[(2-chloro-6-fluorophenyl)methyl]piperazin-1-yl]propan-1-amine
C14H21ClFN3 (285.14079480000004)
N-Methyl-N-(2-(4-aminophenoxy)ethyl)-2-(4-aminophenyl)ethanamine
ETHYL1-(TERT-BUTOXYCARBONYLAMINO)-4-OXOCYCLOHEXANECARBOXYLATE
3-Amino-1-propyl-5H-pyrido(4,3-b)indole acetate
C16H19N3O2 (285.14771939999997)
3-Amino-4-ethyl-1-methyl-5H-pyrido(4,3-b)indole acetate
C16H19N3O2 (285.14771939999997)
(+)-(1R,2R)-O-DESMETHYL TRAMADOL HCL
C15H24ClNO2 (285.14954739999996)
N-prop-2-ynyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
C16H20BNO3 (285.15361600000006)
5-tert-butyl-1-[2-(2-hydroxyethylsulfanyl)ethyl]-2-methylpyrrole-3-carboxylic acid
tert-butyl N-[(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate
C14H27N3O3 (285.20523119999996)
3-((4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)METHYL)PYRIDINE
2-((4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)METHYL)PYRIDINE
(S)-TERT-BUTYL 3-(TERT-BUTYLCARBAMOYL)PIPERAZINE-1-CARBOXYLATE
C14H27N3O3 (285.20523119999996)
(-)-O-DESMETHYLTRAMADOL, HYDROCHLORIDE
C15H24ClNO2 (285.14954739999996)
(R)-4-BOC-PIPERAZINE-2-CARBOXYL-T-BUTYLAMIDE
C14H27N3O3 (285.20523119999996)
cis-3,4,5-Trimethoxy-3-aminostilbene
C17H19NO3 (285.13648639999997)
Prolyl-leucyl-glycine
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
L-alanyl-L-alanine 2-naphthylamide
C16H19N3O2 (285.14771939999997)
(2S)-2-[[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]-4-methylpentanoic acid
2,4-Dimethyl-5-[(2-methylphenyl)hydrazinylidene]-3-pyrrolecarboxylic acid ethyl ester
C16H19N3O2 (285.14771939999997)
(1R,7aS)-hexahydro-1H-pyrrolizin-1-ylmethyl 2,3-dihydroxy-2-(propan-2-yl)butanoate
(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-YL 1H-pyrrolo[2,3-B]pyridine-3-carboxylate
C16H19N3O2 (285.14771939999997)
5-Amino-6-cyclohexyl-4-hydroxy-2-isobutyl-hexanoic acid
Unkie
C17H19NO3 (285.13648639999997)
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist > C1657 - Opiate N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AA - Natural opium alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
(hexahydro-1H-pyrrolizin-1-yl)methyl 2,3-dihydroxy-2-(propan-2-yl)butanoate
(S)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-7-methoxyisoquinoline-6-ol
C17H19NO3 (285.13648639999997)
N-Propionyl-N-(4,6,7-trimethyl-quinazolin-2-yl)-guanidine
N-[4-(diethylamino)benzylidene]-2-furohydrazide
C16H19N3O2 (285.14771939999997)
1-(6-hydroxy-3,6-dimethyl-4-phenyl-5,7-dihydro-4H-2,1-benzoxazol-5-yl)ethanone
C17H19NO3 (285.13648639999997)
[(1S,5R)-8-methyl-8-azoniabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate
2-(2,5-dimethylphenoxy)-N-(2-hydroxy-5-methylphenyl)acetamide
C17H19NO3 (285.13648639999997)
9-oxo-N-(1-phenylethyl)bicyclo[3.3.1]nonane-3-carboxamide
3-[5-(4-Methoxyphenyl)-1-prop-2-enyl-2-pyrrolyl]propanoic acid
C17H19NO3 (285.13648639999997)
(2,6-Dimethyl-phenoxy)-acetic acid (1-methyl-1H-pyrrol-2-ylmethylene)-hydrazide
C16H19N3O2 (285.14771939999997)
1-(2-Ethyl-3-benzofuranyl)-3-(1-piperidinyl)-1-propanone
1-[2-(Prop-2-en-1-ylphenoxy)]-3-(isopropylamino)propan-2-ol hydrochloride
C15H24ClNO2 (285.14954739999996)
N,N-di(propan-2-yl)-2-[(1-propyl-5-tetrazolyl)thio]acetamide
8-fluoro-4-(4-methylpiperazin-1-yl)-5H-pyrimido[5,4-b]indole
(E)-1-hydroxy-2-(non-1-en-1-yl)quinolin-4-one
A hydroxylamine that is N-hydroxyquinolin-4-one in which the hydrogen at position 2 has been replaced by a (1E)-non-1-en-1-yl group. It is the most active agent produced by Pseudomonas aeruginosa that modulates the growth and virulence of Staphylococcus aureus; the corresponding Z isomer is inactive.
4-[Methyl-(phenylmethyl)amino]-1-phenylbutane-1,3-diol
(4R,7S,7aR,12bS)-3-methyl-2,4,6,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
C17H19NO3 (285.13648639999997)
11-Oxomiltiradiene(1-)
An organic anion that is the conjugate base of 11-oxomiltiradiene, arising from the deprotonation of the methylene group at position 14. Major species at pH 7.3.
2-(2,3-Dimethoxyphenyl)-3-phenylpropionamide
C17H19NO3 (285.13648639999997)
Morphine
C17H19NO3 (285.13648639999997)
A morphinane alkaloid that is a highly potent opiate analgesic psychoactive drug. Morphine acts directly on the central nervous system (CNS) to relieve pain but has a high potential for addiction, with tolerance and both physical and psychological dependence developing rapidly. Morphine is the most abundant opiate found in Papaver somniferum (the opium poppy). D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist > C1657 - Opiate N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AA - Natural opium alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
Talwin
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics
N-Myristoylglycine
An N-acylglycine in which the acyl group is specified as myristoyl (tetradecanoyl).
(2E)-octenoylcarnitine
An O-acylcarnitine having (2E)-octenoyl as the acyl substituent.
O-octenoylcarnitine
An O-acylcarnitine in which the acyl group specified is octenoyl.
Octenoyl-L-carnitine
An O-acyl-L-carnitine that is L-carnitine having a octenoyl group as the acyl substituent in which the position of the double bond is unspecified.
2-octenoyl-L-carnitine
An octenoyl-Lcarnitine having 2-octenoyl as the acyl substituent.
(3s,4r)-3-[(s)-hydroxy(phenyl)methyl]-1-methyl-4-(1-methylimidazol-4-yl)pyrrolidin-2-one
C16H19N3O2 (285.14771939999997)
11-hydroxy-12-methyl-5-phenyl-6-oxa-12-azatricyclo[7.2.1.0²,⁷]dodec-2(7)-en-3-one
C17H19NO3 (285.13648639999997)
(1r,4'r)-11'-hydroxy-10'-methoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one
C17H19NO3 (285.13648639999997)
(2s,3s,4r)-3-methyl-2-[(1e,3e)-4-phenylbuta-1,3-dien-1-yl]piperidin-4-yl acetate
(1s)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-8-ol
C17H19NO3 (285.13648639999997)
(1r,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate
(2r,4s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 2-phenylprop-2-enoate
C17H19NO3 (285.13648639999997)
1-[(5s)-2,4-dihydroxy-5-isopropyl-5h-pyrrol-3-yl]-5-hydroxy-3-methoxyhexan-1-one
1-[(3-hydroxyphenyl)methyl]-6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol
C17H19NO3 (285.13648639999997)
(1s,5r,13r,14r,17r)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10,15-tetraene-10,14-diol
C17H19NO3 (285.13648639999997)
1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol
C17H19NO3 (285.13648639999997)
n-[(4s,5r,7s,9s)-7-ethyl-9-hydroxy-8,8-dimethyl-2-oxo-1,6-dioxaspiro[4.5]decan-4-yl]ethanimidic acid
(4e)-5-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one
C17H19NO3 (285.13648639999997)
n-[(2r,3s)-3-(acetyloxy)dodecan-2-yl]ethanimidic acid
(9bs,11s)-8,11-dimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline
3,6-bis({[(2r)-3,3-dimethyloxiran-2-yl]methyl})-1h-indole
n-[2-(2,2-dimethylchromen-6-yl)ethyl]-3-methylbut-2-enimidic acid
(2e,4e,10z)-1-(piperidin-1-yl)tetradeca-2,4,10-trien-8-yn-1-one
n-(2-methylpropyl)pentadeca-2,9-dien-12,14-diynimidic acid
2-(nonan-8-one)-(1h)-4-quinolone
{"Ingredient_id": "HBIN006129","Ingredient_name": "2-(nonan-8-one)-(1h)-4-quinolone","Alias": "NA","Ingredient_formula": "C18H23NO2","Ingredient_Smile": "COC1C2=CC=CC=C2NC(=O)C1(CCC=C)CCC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15682","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methyl-butyric acid [(1R,8R)-pyrrolizidin-1-yl]methyl ester
{"Ingredient_id": "HBIN006594","Ingredient_name": "(2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methyl-butyric acid [(1R,8R)-pyrrolizidin-1-yl]methyl ester","Alias": "(2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methylbutanoic acid [(1R,8R)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl ester; [(1R,8R)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methyl-butanoate; 487-99-0; [(1R,8R)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methylbutanoate; Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (hexahydro-1H-pyrrolizin-1-yl)methyl ester, (1R-(1alpha(2S*,3R*),7abeta))-","Ingredient_formula": "C15H27NO4","Ingredient_Smile": "CC(C)C(C(C)O)(C(=O)OCC1CCN2C1CCC2)O","Ingredient_weight": "285.38","OB_score": "18.84516742","CAS_id": "487-99-0","SymMap_id": "SMIT03157","TCMID_id": "NA","TCMSP_id": "MOL000599","TCM_ID_id": "NA","PubChem_id": "164622","DrugBank_id": "NA"}
3,3-dimethylallyl-4-methoxy-2-quinolone
{"Ingredient_id": "HBIN007181","Ingredient_name": "3,3-dimethylallyl-4-methoxy-2-quinolone","Alias": "NA","Ingredient_formula": "C18H23NO2","Ingredient_Smile": "COC1C2=CC=CC=C2NC(=O)C1(CCC=C)CCC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15154","TCMID_id": "6307","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-dimethylallyl-4-methoxy-2-quinolone
{"Ingredient_id": "HBIN008441","Ingredient_name": "3-dimethylallyl-4-methoxy-2-quinolone","Alias": "NA","Ingredient_formula": "C18H23NO2","Ingredient_Smile": "COC1C2=CC=CC=C2NC(=O)C1(CCC=C)CCC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25844","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
aposcopolamine
C17H19NO3 (285.13648639999997)
{"Ingredient_id": "HBIN016515","Ingredient_name": "aposcopolamine","Alias": "535-26-2; Prestwick_216; Aposcopolamine","Ingredient_formula": "C17H19NO3","Ingredient_Smile": "CN1C2CC(CC1C3C2O3)OC(=O)C(=C)C4=CC=CC=C4","Ingredient_weight": "285.34 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14344","TCMID_id": "1534","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "98104494","DrugBank_id": "NA"}
1-[(4-hydroxyphenyl)methyl]-2-methyl-3,4-dihydro-1h-isoquinoline-6,7-diol
C17H19NO3 (285.13648639999997)
(1s)-1-[(4-hydroxyphenyl)methyl]-2-methyl-3,4-dihydro-1h-isoquinoline-6,7-diol
C17H19NO3 (285.13648639999997)
(2e,9z)-n-(2-methylpropyl)pentadeca-2,9-dien-12,14-diynimidic acid
(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate
(1r)-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol
C17H19NO3 (285.13648639999997)
(1r,2r,4r,5s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 2-phenylprop-2-enoate
C17H19NO3 (285.13648639999997)
11-methoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-7,8-diol
C17H19NO3 (285.13648639999997)
4,5-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraen-12-one
C17H19NO3 (285.13648639999997)
(1r,2s,4r,5s,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 2-phenylprop-2-enoate
C17H19NO3 (285.13648639999997)
(3s)-3-{[(2e,4e,6e)-1-hydroxyocta-2,4,6-trien-1-ylidene]amino}-3-phenylpropanoic acid
C17H19NO3 (285.13648639999997)
(2s,6r,7s,8r)-7-[(1e)-buta-1,3-dien-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol
(2s,3s)-n-[(1s)-1-(c-hydroxycarbonimidoyl)-3-methylbutyl]-2-[(1-hydroxyethylidene)amino]-3-methylpentanimidic acid
C14H27N3O3 (285.20523119999996)
(1s,13r)-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene
C17H19NO3 (285.13648639999997)
3,4,6-trimethoxy-1,2-dimethyl-9h-carbazole
C17H19NO3 (285.13648639999997)
n-[(2s)-2-methoxy-2-(4-methoxyphenyl)ethyl]benzenecarboximidic acid
C17H19NO3 (285.13648639999997)
(11r)-11-methoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-7,8-diol
C17H19NO3 (285.13648639999997)
8,11-dimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline
(4e)-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-5-(2-methylphenyl)pent-4-enimidic acid
C17H19NO3 (285.13648639999997)
3,5-bis({[(2r)-3,3-dimethyloxiran-2-yl]methyl})-1h-indole
(2s,6r,7s,8s)-7-[(1z)-but-1-en-3-yn-1-yl]-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol
3-(1h-indol-3-ylmethyl)-6-isopropyl-3,6-dihydropyrazine-2,5-diol
C16H19N3O2 (285.14771939999997)
n-[(2r)-2-methoxy-2-(4-methoxyphenyl)ethyl]benzenecarboximidic acid
C17H19NO3 (285.13648639999997)
(1s)-1-[(3-hydroxyphenyl)methyl]-6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol
C17H19NO3 (285.13648639999997)
n-[1-(c-hydroxycarbonimidoyl)-3-methylbutyl]-2-[(1-hydroxyethylidene)amino]-3-methylpentanimidic acid
C14H27N3O3 (285.20523119999996)
n-methyl-n-(2-methylpropyl)tetradeca-2,4-dien-8,10-diynamide
(4e,7e)-7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid
3-[(1-hydroxyocta-2,4,6-trien-1-ylidene)amino]-3-phenylpropanoic acid
C17H19NO3 (285.13648639999997)
(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2,3-dihydroxy-2-isopropylbutanoate
(3e)-4-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-2-yl)-2-methylbut-3-en-2-ol
7-(but-1-en-3-yn-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol
3,6-bis({[(2s)-3,3-dimethyloxiran-2-yl]methyl})-1h-indole
(1r,5s,9r,11r)-11-hydroxy-12-methyl-5-phenyl-6-oxa-12-azatricyclo[7.2.1.0²,⁷]dodec-2(7)-en-3-one
C17H19NO3 (285.13648639999997)
3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-5-{[(2s)-3,3-dimethyloxiran-2-yl]methyl}-1h-indole
3,5-bis[(3,3-dimethyloxiran-2-yl)methyl]-1h-indole
4-(4-hydroxyphenyl)-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol
C17H19NO3 (285.13648639999997)
4-{3-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-6-yl}-2-methylbut-3-en-2-ol
(3s,6s)-3-(1h-indol-3-ylmethyl)-6-isopropyl-3,6-dihydropyrazine-2,5-diol
C16H19N3O2 (285.14771939999997)
(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate
4-(4-hydroxyphenyl)-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-5-ol
C17H19NO3 (285.13648639999997)
4-{3-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-5-yl}-2-methylbut-3-en-2-ol
(1r,13s,15r)-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene
C17H19NO3 (285.13648639999997)
(3e)-4-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-5-yl)-2-methylbut-3-en-2-ol
(1s,13s,15r)-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene
C17H19NO3 (285.13648639999997)
15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene
C17H19NO3 (285.13648639999997)
(9bs,11r)-11-methoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-7,8-diol
C17H19NO3 (285.13648639999997)
(2s)-2-{[(benzyloxy)(hydroxy)methylidene]amino}-3-phenylpropan-1-ol
C17H19NO3 (285.13648639999997)
7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid
(1r)-1-[(4-hydroxyphenyl)methyl]-2-methyl-3,4-dihydro-1h-isoquinoline-6,7-diol
C17H19NO3 (285.13648639999997)
3-{[(2e,4e,6e)-1-hydroxyocta-2,4,6-trien-1-ylidene]amino}-3-phenylpropanoic acid
C17H19NO3 (285.13648639999997)
(2s,3r,4s)-3-hydroxy-6-{[(2e)-1-hydroxy-2-methylpent-2-en-1-ylidene]amino}-2,4-dimethyl-5-oxohexanoic acid
(1r,10s)-4,5-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraen-12-one
C17H19NO3 (285.13648639999997)
(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate
3,6-bis[(3,3-dimethyloxiran-2-yl)methyl]-1h-indole
(9bs,11r)-7-methoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-8,11-diol
C17H19NO3 (285.13648639999997)
(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate
1-(piperidin-1-yl)tetradeca-2,4,10-trien-8-yn-1-one
(1r,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate
8-methoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-7,11-diol
C17H19NO3 (285.13648639999997)
7-methoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-8,11-diol
C17H19NO3 (285.13648639999997)
n-{7-ethyl-9-hydroxy-8,8-dimethyl-2-oxo-1,6-dioxaspiro[4.5]decan-4-yl}ethanimidic acid
(2e,4e)-n-methyl-n-(2-methylpropyl)tetradeca-2,4-dien-8,10-diynamide
2,3-dihydroxy-n-(2-phenylethyl)nona-6,8-diynimidic acid
C17H19NO3 (285.13648639999997)
(1s,13r,15r)-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene
C17H19NO3 (285.13648639999997)
4-{3-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-2-yl}-2-methylbut-3-en-2-ol
(2e)-1-[(3r,4r)-3,4-diacetylpyrrolidin-1-yl]-3-phenylprop-2-en-1-one
C17H19NO3 (285.13648639999997)
(1s,4'r)-11'-hydroxy-10'-methoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one
C17H19NO3 (285.13648639999997)
(2s,6r,7s,8r)-7-(buta-1,3-dien-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol
(1r,2r,4s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 2-phenylprop-2-enoate
C17H19NO3 (285.13648639999997)
(3z)-4-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-6-yl)-2-methylbut-3-en-2-ol
(3e)-4-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-6-yl)-2-methylbut-3-en-2-ol
(4e)-7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid
4,15-dimethoxy-10-azatetracyclo[8.6.1.0²,⁷.0¹³,¹⁷]heptadeca-2,4,6,13-tetraene
(9bs,11r,13as)-8,11-dimethoxy-1h,2h,4h,5h,10h,11h,13ah-indolo[7a,1-a]isoquinoline
(1r)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-8-ol
C17H19NO3 (285.13648639999997)
1-[(4-hydroxyphenyl)methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-8-ol
C17H19NO3 (285.13648639999997)
2,4-dihydroxy-n-(2-phenylethyl)nona-6,8-diynimidic acid
C17H19NO3 (285.13648639999997)
(4s)-4-(4-hydroxyphenyl)-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-5-ol
C17H19NO3 (285.13648639999997)
1-(2,4-dihydroxy-5-isopropyl-5h-pyrrol-3-yl)-5-hydroxy-3-methoxyhexan-1-one
(1s,5s,9s,11r)-11-hydroxy-12-methyl-5-phenyl-6-oxa-12-azatricyclo[7.2.1.0²,⁷]dodec-2(7)-en-3-one
C17H19NO3 (285.13648639999997)
(2e,4e)-n-(3-methylbutyl)tetradeca-2,4-dien-8,10-diynimidic acid
8,11-dimethoxy-1h,2h,4h,5h,10h,11h,13ah-indolo[7a,1-a]isoquinoline
3-[hydroxy(phenyl)methyl]-1-methyl-4-(1-methylimidazol-4-yl)pyrrolidin-2-one
C16H19N3O2 (285.14771939999997)
(1r,13r,15r)-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene
C17H19NO3 (285.13648639999997)
11'-hydroxy-10'-methoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one
C17H19NO3 (285.13648639999997)
(2e)-14-methyl-1-sulfinylidenepentadec-2-en-1-amine
n-[2-methoxy-2-(4-methoxyphenyl)ethyl]benzenecarboximidic acid
C17H19NO3 (285.13648639999997)
2-{[(benzyloxy)(hydroxy)methylidene]amino}-3-phenylpropan-1-ol
C17H19NO3 (285.13648639999997)